REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 679.00
Bid: 680.50
Ask: 681.00
Change: -3.50 (-0.51%)
Spread: 0.50 (0.073%)
Open: 681.50
High: 688.50
Low: 679.00
Prev. Close: 682.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

11 Jan 2024 13:00

RNS Number : 4126Z
Tate & Lyle PLC
11 January 2024

Tate & Lyle PLC

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the 'Company') has been informed that on 9 January 2024 the following transactions occurred by Persons Discharging Managerial Responsibilities ('PDMR'), in respect of their interest in ordinary shares of 29 1/6 pence each in the capital of the Company ('Shares') under the Dividend Reinvestment Plan ('DRIP').

PDMR

Number of Shares acquired under the DRIP

Price

William Magee

448.872428

£6.465044

Andrew Taylor

3,200.097323

£6.465044

Victoria Spadaro Grant

566.177209

£6.465043

The notifications below, which have been made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Claire-Marie O'Grady

Company Secretary

11 January 2024

Notification and public disclosure of transaction by person discharging managerial responsibilities

Details of PDMR / person closely associated with them ("PCA")

a)

Name

William Magee

2.

Reason for the notification

a)

Position / status

President, Food & Beverage Solutions, North America

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

GB00BP92CJ43

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 6.465044

448.872428

d)

Aggregated information

- Aggregated volume

- Price

448.872428

GBP 2,901.98

e)

Date of the transaction

2024-01-09

f)

Place of the transaction

London Stock ExchangeXLON

Notification and public disclosure of transaction by person discharging managerial responsibilities

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew Taylor

2.

Reason for the notification

a)

Position / status

President, Asia, Middle East, Africa and Latin America

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

GB00BP92CJ43

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 6.465044

3,200.097323

d)

Aggregated information

- Aggregated volume

- Price

3,200.097323

GBP 20,688.77

e)

Date of the transaction

2024-01-09

f)

Place of the transaction

London Stock ExchangeXLON

Notification and public disclosure of transaction by person discharging managerial responsibilities

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Victoria Spadaro Grant

2.

Reason for the notification

a)

Position / status

President, Innovation and Commercial Development

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

GB00BP92CJ43

b)

Nature of the transaction

Acquisition of shares under the Tate & Lyle PLC Dividend Reinvestment Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 6.465043

566.177209

d)

Aggregated information

- Aggregated volume

- Price

566.177209

GBP 3,660.36

e)

Date of the transaction

2024-01-09

f)

Place of the transaction

London Stock ExchangeXLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUAVARSNUAAAR
Date   Source Headline
4th Nov 20217:00 amRNSHalf-year Report
3rd Nov 20216:01 pmRNSDirectorate Change
29th Oct 202111:15 amRNSHolding(s) in Company
21st Oct 20214:45 pmRNSRestatement re Primary Products Disposal
18th Oct 20212:30 pmRNSHolding(s) in Company
13th Oct 202112:30 pmRNSHolding(s) in Company
6th Oct 20213:30 pmRNSHolding(s) in Company
6th Oct 202111:15 amRNSDirector/PDMR Shareholding
4th Oct 20212:30 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSTotal Voting Rights
30th Sep 202112:00 pmRNSResult of General Meeting
13th Sep 20214:30 pmRNSCircular re. KPS Partnership
1st Sep 20219:58 amRNSTotal Voting Rights
18th Aug 202110:10 amRNSDirector/PDMR Shareholding
11th Aug 20214:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20213:15 pmRNSTotal Voting Rights
29th Jul 202112:45 pmRNSResult of AGM
23rd Jul 20215:00 pmRNSHolding(s) in Company
22nd Jul 20213:15 pmRNSDirector/PDMR Shareholding
16th Jul 20213:30 pmRNSHolding(s) in Company
12th Jul 20214:00 pmRNSHolding(s) in Company
12th Jul 20213:50 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSTate & Lyle to be re-positioned as growth business
8th Jul 20213:30 pmRNSHolding(s) in Company
8th Jul 20213:14 pmRNSHolding(s) in Company
1st Jul 20214:40 pmRNSBlock listing Interim Review
1st Jul 20214:38 pmRNSTotal Voting Rights
15th Jun 20212:15 pmRNSAnnual Financial Report
14th Jun 20212:05 pmRNSHolding(s) in Company
14th Jun 20212:00 pmRNSHolding(s) in Company
9th Jun 20213:49 pmRNSDirector/PDMR Shareholding
1st Jun 20212:34 pmRNSTotal Voting Rights
27th May 20217:00 amRNSFinal Results
4th May 202111:30 amRNSTotal Voting Rights
28th Apr 202110:00 amRNSDirectorate Change
26th Apr 20217:00 amRNSResponse to media speculation
13th Apr 20213:45 pmRNSHolding(s) in Company
1st Apr 202112:00 pmRNSTotal Voting Rights
25th Mar 202110:00 amRNSDirectorate Changes
23rd Mar 20213:00 pmRNSHolding(s) in Company
12th Mar 202111:00 amRNSDirector Declaration
1st Mar 202111:00 amRNSTotal Voting Rights
26th Feb 202111:00 amRNSDirector Declaration
15th Feb 20214:43 pmRNSHolding(s) in Company
15th Feb 20214:40 pmRNSHolding(s) in Company
15th Feb 20214:37 pmRNSHolding(s) in Company
10th Feb 202111:15 amRNSAcquisition
28th Jan 20217:00 amRNSTrading Statement
21st Jan 20217:00 amRNSVivid Sehgal Appointed Chief Financial Officer
12th Jan 20213:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.